| ESPR Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the ESPR market cap history going back to 6/26/2013:
Also see: ESPR Shares Outstanding History and ESPR YTD Return |
ESPR Market Cap History — Esperion Therapeutics Capitalization Over Time
As of 10/31/2025 Esperion Therapeutics has a market cap of 710.02 million. Investors often follow the ESPR market cap history to compare the size of the company over time.
This page shows ESPR market capitalization trends over time, with 39 market cap datapoints presented, dating back to 6/26/2013.
| ESPR Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ESPR Historical Market Cap: +10.61% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ESPR Stock Price Chart |
| About Esperion Therapeutics Inc (New) |
| Esperion Therapeutics, Inc. is a pharmaceutical company. Co. is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Co.'s products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. Co.'s NEXLETOL and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD). We show 39 historical shares outstanding datapoints in our ESPR shares outstanding history coverage, used to compute ESPR market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing ESPR market cap history over the course of time is important for investors interested in comparing ESPR's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of ESPR versus a peer is one thing; comparing ESPR market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like ESPR can fluctuate over the course of history. With this page we aim to empower investors researching ESPR by allowing them to research the ESPR market cap history. |
| ESPR Current Stock Quote |
Quotes delayed 20 minutes  Free ESPR Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| ESPR Share Performance |
| Market Cap Peers |
| Esperion Therapeutics (ESPR) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
ESRX Market Cap History ETHZ Market Cap History ETNB Market Cap History ETON Market Cap History ETTX Market Cap History EVFM Market Cap History EVHC Market Cap History EVLO Market Cap History EVOK Market Cap History EW Market Cap History More Healthcare companies » |
ESPR Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
